Cystic fibrosis affects around 100,000 people worldwide, and for many years was considered a life-limiting condition. However, a study this year projected that treatment with drugs such as Trikafta (comprising elexacaftor, tezacaftor and ivacaftor) — approved by the US Food and Drug Administration in 2019 — can increase life expectancy from around 30 to more than 80 years2.

I hadn’t heard of Trifakta before, this is wonderful news! It seems we are on the verge of curing many formerly incurable diseases.

This is why our lives are better than those of our ancestors, the incremental work of dedicated scientists like these. They have my deepest appreciation and thanks.